awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37461942-1AEDDE67-01E8-4C52-BB7D-A06978A5E673
Q37461942-1AEDDE67-01E8-4C52-BB7D-A06978A5E673
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37461942-1AEDDE67-01E8-4C52-BB7D-A06978A5E673
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.
P2860
Q37461942-1AEDDE67-01E8-4C52-BB7D-A06978A5E673
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37461942-1AEDDE67-01E8-4C52-BB7D-A06978A5E673
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e7760ca51b822bceb2cb21644cc706e9a1c37a4
P2860
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.